The Use of Biological Markers in Toxicology

References

• Committee on Biological Markers of the National Research Council. Biological markers in environmental health research. Environ. Health Perspect 1987; 74: 3
   PubMed Web of Science ®Google Scholar
• Ashford N. A. Policy considerations for human monitoring in the workplace. J. Occup. Med. 1986; 28: 563
   PubMedGoogle Scholar
• Modeling of Inhalation Exposure to Vapors: Uptake, Distribution and Elimination, V. Fiserova-Bergerova. CRC Press, Boca Raton, FL 1983; Vol. I and II
   Google Scholar
• Duteher J. S., Medinsky M. A., Bond J. A., Cheng Y. S., Snipes M. B., Henderson R. F., Birnbaum L. S. Effect of vapor concentration on the disposition of inhaled 2,3-dichloropropene in Fischer-344 rats. Fundam. Appl. Toxicol. 1985; 5: 997
   PubMedGoogle Scholar
• Bond J. A., Medinsky M. A., Duteher J. S., Henderson R. F., Cheng Y. S., Mewhinney J. A. Disposition and metabolism of14C-2,3-dichloropropene in rats after inhalation. Toxicol. Appl. Pharmacol. 1985; 78: 47
   PubMed Web of Science ®Google Scholar
• Medinsky M. A., Duteher J. S., Bond J. A., Henderson R. F., Mauderiy J. L., Snipes M. B., Mewhinney J. A., Cheng Y. S., Birnbaum L. S. Uptake and excretion of14C-methyl bromide as influenced by exposure concentration. Toxicol. Appl. Pharmacol. 1985; 78: 215
   PubMed Web of Science ®Google Scholar
• Bond J. A., Duteher J. S., Medinsky M. A., Henderson R. F., Cheng Y. S., Mewhinney J. A., Birnbaum L. S. Disposition and metabolism of14C-methyl bromide in rats after inhalation. Toxicol. Appl. Pharmacol. 1985; 78: 259
   PubMed Web of Science ®Google Scholar
• Bond J. A., Dahl A. R., Henderson R. F., Duteher J. S., Mauderiy J. L., Birnbaum L. S. Species differences in the disposition of inhaled butadiene. Toxicol. Appl. Pharmacol. 1986; 84: 617
   PubMed Web of Science ®Google Scholar
• Dahl A. R., Birnbaum L. S., Bond J. A., Gervasi P. G., Henderson R. F. The fate of isoprene inhaled by rats: comparison to butadiene. Toxicol. Appl. Pharmacol. 1987; 89: 237
   PubMed Web of Science ®Google Scholar
• Andersen M. E. Saturable metabolism and its relationship to toxicity, Cm. Rev. Toxicol. 1981; 2: 105
   Google Scholar
• Gillette J. R. Pharmacokinetic factors governing the steady-state concentrations of foreign chemicals and their metabolites. Ciba Found. Symp. 1980; 76: 191
   PubMedGoogle Scholar
• Sabourin P. J., Beentold W. E., Birnbaum L. S., Lucier G. W., Henderson R. F. Difference in the metabolism of inhaled3H-benzene by F344/N rats and B6C3F, mice. Toxicol. Appl. Pharmacol. 1988; 94: 128
   PubMed Web of Science ®Google Scholar
• Bolt H. M., Filser J. G., Stoermer F. Inhalation pharmacokinetics based on gas uptake studies. V. Comparative pharmacokinetics of ethylene and 1,3-butadiene in rats. Arch. Toxicol. 1984; 55: 213
   PubMed Web of Science ®Google Scholar
• Henderson R. F., Sabourin P. J., Beentold W. E., Griffith W. C., Medinsky M. A., Birnbaum L. S., Lucier G. W. The effect of dose, dose rate, route of administration and species on tissue and blood levels of benzene metabolites. Environ. Health Perspect 1989; 82: 9
   PubMed Web of Science ®Google Scholar
• Sabourin P. J., Beentold W. E., Griffith W. C., Birnbaum L. S., Lucier G. W., Henderson R. F. Effect of exposure concentration, exposure rate, and route of adminstration on metabolism of benzene by F344 rats and B6C3F, mice. Toxicol. Appl. Pharmacol. 1989; 99: 421
   PubMed Web of Science ®Google Scholar
• Medinsky M. A., Sabourin P. J., Henderson R. F., Lucier G. W., Birnbaum L. S. Differences in the pathways for metabolism of benzene in rats and mice simulated by a physiological model. Environ. Health Perspect 1989; 82: 43
   PubMed Web of Science ®Google Scholar
• Medinsky M. A., Sabourin P. J., Lucier G. W., Birnbaum L. S., Henderson R. F. A physiological model for simulation of benzene metabolism by rats and mice. Toxicol. Appl. Pharmacol. 1989; 99: 193
   PubMed Web of Science ®Google Scholar
• Bond J. A., Benson J. M., Sun J. D. Use of radiolabeling in environmental and lexicological research. Hazard Assessment of Chemicals, J. Saxena. Hemisphere, Washington, DC 1986; Vol. 5: 29
   Google Scholar
• Garner C., Ryder R., Montesano R. Monitoring of aflatoxins in human body fluids and application to field studies. Cancer Res. 1985; 45: 922
   Web of Science ®Google Scholar
• Documentation of the threshold limit values and biological exposure indices, 5th ed. American Conference of Governmental Industrial Hygienists, Inc. (ACGIHI). 1986, BEI-1
   Google Scholar
• Zhu J., Zhang L., Hu X., Xiao Y., Chen J., Xu Y., Fremy J., Chu F. S. Correlation of dietary aflatoxin B, levels with excretion of aflatoxin M, in human urine. Cancer Res. 1987; 47: 1848
   PubMed Web of Science ®Google Scholar
• Becher G. Determination of exposure to PAH by analysis of urine samples. Mechanisms in Tobacco Carcinogenesis, D. Hoffman, C. C. Harris. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 1986; 33, Banbury Report 23
   Google Scholar
• Wallace L. A. Office of Acid Deposition, Environmental Monitoring and Quality Assurance, Washington, DC 1987, The Total Exposure Assessment Methodology (TEAM) Study: Summary and Analysis: Volume I, Report EPA 600/6-87/002a, U.S. Environmental Protection Agency
   Google Scholar
• Patterson D. G., Jr., Hoffman R. E., Needham L. L., Roberts D. W., Bagby J. R., Pirkle J. L., Falk H., Sampson E. J., Houk V. N. 2,3,7,8-Tetrachlorodibenzo-p-dioxin levels in adipose tissue of exposed and control persons in Missouri. JAMA 1986; 256: 2683
   PubMed Web of Science ®Google Scholar
• Anderson H. A. Utilization of adipose tissue biopsy in characterizing human halogenated hydrocarbon exposure. Environ. Health Perspect 1985; 60: 127
   PubMed Web of Science ®Google Scholar
• Lucas R. M., Iannacchione V. G., Melroy D. K. Polychlorinated Biphenyls in Human Adipose Tissue and Mother's Milk. U.S. Environmental Protection Agency, Washington, DC 1982
   Google Scholar
• Roggli V. L., Piantadosi C. A., Bell D. Y. Asbestos bodies in bronchoalveolar lavage fluid. Acta Cytol. 1986; 30: 470
   PubMedGoogle Scholar
• Niejadlik D. C. Sputum. Clinical Diagnosis and Management by Laboratory Methods, 17th ed., J. C. Todd, A. H. Sanford, I. Davidson, J. Henry. W. B. Saunders, Philadelphia 1984
   Google Scholar
• Wieczorek H., Piotrowski J. K. Evaluation of low exposure to styrene. Int. Arch. Occup. Environ. Health 1985; 57: 57
   PubMed Web of Science ®Google Scholar
• Loef A., Lundgren E., Nordquist M. B. Kinetics of styrene in workers from a plastics industry after controlled exposure: a comparison with subjects not previously exposed. Br. J. Ind. Med. 1986; 43: 537
   PubMedGoogle Scholar
• Ohtsuji H., Ikeda M. A rapid colorimetric method for the determination of phenylglyoxylic and mandelic acids, Br. J. Ind. Med. 1970; 27: 150
   Google Scholar
• Engstrom K., Harkonen H., Kalliokoski P., Rantanen J. Urinary mandelic acid concentration after occupational exposure to styrene and its use as a biological exposure test. Scand. J. Work Environ. Health 1976; 2: 21
   PubMedGoogle Scholar
• Wolff M. S., Damn S. M., Lorimer W. V., Selikoff I. J. Styrene and related hydrocarbons in subcutaneous fat from polymerization workers. J. Toxicol. Environ. Health 1977; 2: 997
   PubMed Web of Science ®Google Scholar
• Engstrom J., Bjurstrom R., Astrand L., Ovrum P. Uptake, distribution and elimination of styrene in man. Scand. J. Work Environ. Health 1978; 4: 315
   PubMed Web of Science ®Google Scholar
• Andersen M. E., Gargas M. L., Ramsey J. C. Inhalation pharmacokinetics: evaluating systemic extraction, totalin vivo metabolism, and the time course of enzyme induction for inhaled styrene in rats based on arterial blood:inhaled air concentration ratios. Toxicol. Appl. Pharmacol. 1984; 73: 176
   PubMed Web of Science ®Google Scholar
• Ramsey J. C., Andersen M. E. A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol. Appl. Pharmacol. 1984; 73: 159
   PubMed Web of Science ®Google Scholar
• Ramsey J. C., Young J. D., Karbowski R. J., Chenoweth M. B., McCarty L. P., Braun W. H. Pharmacokinetics of inhaled styrene in human volunteers. Toxicol. Appl. Pharmacol. 1980; 53: 54
   PubMed Web of Science ®Google Scholar
• Cohen S. I., Perkins N. M., Ury H. K., Goldsmith J. R. Carbon monoxide uptake in cigarette smoking. Arch. Environ. Health 1971; 22: 55
   PubMed Web of Science ®Google Scholar
• Russell M. A. H., Wilson C., Patel U. A., Cole P. V., Feyerabend C. Comparison of effect on tobacco consumption and carbon monoxide absorption of changing to high and low nicotine cigarettes. Br. Med. J. 1973; IV: 512
   Google Scholar
• Saloojee Y., Vesey C. J., Cole P. V., Russell M. A. H. Carboxyhaemoglobin and plasma thiocyanate: complementary indicators of smoking behavior?. Thorax 1982; 37: 521
   PubMed Web of Science ®Google Scholar
• DiVicenzo G. D., Kaplan C. J. Uptake, metabolism and elimination of methylene chloride vapor by humans. Toxicol. Appl. Pharmacol. 1981; 59: 130
   PubMed Web of Science ®Google Scholar
• Joumard R., Chiron M., Vidon R., Maurin M., Rouzioux J.-M. Mathematical models of the uptake of carbon monoxide on hemoglobin at low carbon monoxide levels. Environ. Health Perspect 1981; 41: 277
   PubMed Web of Science ®Google Scholar
• Jarvis M. J., Russell M. A. H., Saloojee Y. Expired air carbon monoxide: a simple breath test of tobacco smoke intake. Br. Med. J. 1980; 281: 484
   PubMed Web of Science ®Google Scholar
• Fortmann S. P., Rogers T., Vranizan K., Haskell W. L., Solomon D. S., Farquhar J. W. Indirect measures of cigarette use: expired-air carbon monoxide versus plasma thiocyanate. Prev. Med. 1984; 13: 127
   PubMed Web of Science ®Google Scholar
• Rickert W. S., Robinson J. C. Estimating the hazards of less hazardous cigarettes. II. Study of cigarette yields of nicotine, carbon monoxide and hydrogen cyanide in relation to levels of cotinine, carboxyhaemoglobin and thiocyanate in smokers. J. Toxicol. Environ. Health 1981; 7: 391
   PubMed Web of Science ®Google Scholar
• Borgers D., Junge B. Thiocyanate as an indicator of tobacco smoking. Prev. Med. 1979; 8: 351
   PubMed Web of Science ®Google Scholar
• Pettigrew A. R., Fell G. S. Simplified colorimetric determination of thiocyanate in biological fluids, and its application to investigation of the toxic amblyopias. Clin. Chem. 1972; 18: 996
   PubMed Web of Science ®Google Scholar
• Feyerabend C., Higenbottam T., Russell M. A. H. Nicotine concentrations in urine and saliva of smokers and non-smokers. Br. Med. J. 1982; 284: 1002
   PubMedGoogle Scholar
• Benowitz N. L., Jacob P., III, Jones R. T., Rosenberg J. Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J. Pharmacol. Exp. Ther. 1982; 221: 368
   PubMed Web of Science ®Google Scholar
• Haley N. J., Axelrad C. M., Tilton K. A. Validation of self-reported smoking behavior: biochemical analyses of cotinine and thiocyanate. Am. J. Public Health 1983; 73: 1204
   PubMed Web of Science ®Google Scholar
• Robinson J. C., Young J. C., Rickert W. W., Fey G., Kozlowski L. T. A comparative study of the amount of smoke absorbed from low yield (“less hazardous”) cigarettes. II. Invasive measures. Br. J. Addict. 1983; 78: 79
   PubMedGoogle Scholar
• Pojer R., Whitfield J. B., Poulos V., Eckhard I. F., Richmond R., Hensley W. J. Carboxyhemoglobin, cotinine and thiocyanate assay compared for distinguishing smokers from non-smokers. Clin. Chem. 1984; 30: 1377
   PubMed Web of Science ®Google Scholar
• Benowitz N. L., Hall S. M., Herning R. I., Jacob P., III, Jones R. T., Osman A.-L. Smokers of low-yield cigarettes do not consume less nicotine. New Engl. J. Med. 1983; 309: 139
   PubMed Web of Science ®Google Scholar
• Miller J. A., Miller E. C. Ultimate chemical carcinogens as reactive mutagenic electrophiles. Origins of Human Cancer, H. H. Hiatt, J. D. Watson, J. A. Winsten. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 1977; 605
   Google Scholar
• Gillette J. R. A perspective on the role of chemically reactive metabolites of foreign compounds in toxicity. I. Correlation of changes in covalent binding of reactivity metabolites with changes in the incidence and severity of toxicity. Biochem. Pharmacol. 1974; 23: 2785
   PubMed Web of Science ®Google Scholar
• Wogan G. N., Gorelick N. J. Chemical and biochemical dosimetry of exposure to genotoxic chemicals. Environ. Health Perspect 1985; 62: 5
   PubMed Web of Science ®Google Scholar
• Phillips D. H., Grover P. L., Sims P. The covalent binding of polycyclic hydrocarbons to DNA in the skin of mice of different strains. Int. J. Cancer 1978; 22: 487
   PubMed Web of Science ®Google Scholar
• Pereira M. A., Burns F. J., Albert R. E. Dose response for benzo(a)pyrene adducts in mouse epidermal DNA. Cancer Res. 1979; 39: 2556
   PubMed Web of Science ®Google Scholar
• Adriaenssens P. I., White C. M., Anderson M. W. Dose-response relationships for the binding of benzo(a)pyrene metabolites to DNA and protein in lung, liver, and forestomach of control and butylated hydroxyanisole-treated mice. Cancer Res. 1983; 43: 3712
   PubMed Web of Science ®Google Scholar
• Belinsky S. A., White C. M., Devereux T. R., Anderson M. W. DNA adducts as a dosimeter for risk estimation. Environ. Health Perspect 1987; 76: 3
   PubMed Web of Science ®Google Scholar
• Harris C. C., Weston A., Willey J. C., Trivers G. E., Mann D. L. Biochemical and molecular epidemiology of human cancer: indicators of carcinogen exposure, DNA damage, and genetic predisposition. Environ. Health Perspect 1987; 75: 109
   PubMed Web of Science ®Google Scholar
• Perera F. P., Poirier M. C., Yuspa S. H., Nakayama J., Jaretzki A., Curnen M. M., Knowles D. M., Weinstein I. B. A pilot project in molecular cancer epidemiology: determination of benzo[a]pyrene-DNA adducts in animal and human tissues by immunoassays. Carcinogenesis 1982; 3: 1405
   PubMed Web of Science ®Google Scholar
• Autrup H., Wakhisi J., Vahakangas K., Wasunna A., Harris C. C. Detection of 8,9-dihydro-(7′-guanyl)-9-hydroxyaflatoxin B, in human urine. Environ. Health Perspect 1985; 62: 105
   PubMed Web of Science ®Google Scholar
• Gupta R. C., Reddy M. V., Randerath K. 32P-Postlabeling analysis of non-radioactive aromatic carcinogen-DNA adducts. Carcinogenesis 1982; 3: 1081
   PubMed Web of Science ®Google Scholar
• Wilson V. L., Basu A. K., Essigmann J. M., Smith R. A., Harris C. C. O6-Alkyldeoxyguanosine detection by32P-postlabeling and nucleotide chromatographic analysis. Cancer Res. 1988; 48: 2156
   PubMed Web of Science ®Google Scholar
• Osterman-Golkar S., Ehrenberg D., Seberback D., Hällström I. Evaluation of genetic risks of alkylating agents. II. Haemoglobin as a dose monitor. Mutat. Res. 1976; 34: 1
   PubMed Web of Science ®Google Scholar
• Sun J. D., Dent J. G. A new method for measuring covalent binding of chemicals to cellular macromolecules. Chem. Biol. Interact 1980; 32: 41
   PubMed Web of Science ®Google Scholar
• Ashby J. Comparison of techniques for monitoring human exposure to genotoxic chemicals. Mutat. Res. 1988; 204: 543
   PubMed Web of Science ®Google Scholar
• Neumann H.-G. Analysis for hemoglobin as a dose monitor for alkylating and arylating agents. Arch. Toxicol. 1984; 56: 1
   PubMed Web of Science ®Google Scholar
• Sorsa M., Hemminki K., Vainio H. Biologic monitoring of exposure to chemical mutagens in the occupational environment. Teratogenesis Carcinog. Mutagen. 1982; 2: 137
   PubMedGoogle Scholar
• Mieyal J. J. Monooxygenase activity of hemoglobin and myoglobin. Reviews in Biochemical Toxicology 7, E. Hodgson, J. R. Bend, R. M. Philpot. Elsevier, New York 1985; 1
   Google Scholar
• Pereira M. A., Chang L. W. Binding of chemical carcinogens and mutagens to rat hemoglobin. Chem. Biol. Interact 1981; 33: 301
   PubMed Web of Science ®Google Scholar
• Calleman C. J., Ehrenberg L., Jansson B., Osterman-Golkar S., Segerbäck D., Svensson K., Wachtmeister C. A. Monitoring and risk assessment by means of alkyl groups in hemoglobin in persons occupationally exposed to ethylene oxide. J. Environ. Pathol. Toxicol. 1978; 2: 427
   PubMed Web of Science ®Google Scholar
• Farmer P. B., Bailey E., Gorf B. M., Törnqvist M., Ostermann-Golkar S., Kautiainen A., Lewis-Enright D. P. Monitoring human exposure to ethylene oxide by the determination of hemoglobin adducts using gas chromatography-mass spectrometry. Carcinogenesis 1986; 1: 637
   Google Scholar
• Tannenbaum S. R., Bryant M. S., Skipper P. L., Maclure M. Hemoglobin adducts of tobacco-related aromatic amines: application to molecular epidemiology. Mechanisms in Tobacco Carcinogenesis, D. Hoffman, C. C. Harris. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 1986; 63, Banbury Report 23
   Google Scholar
• Nordquist M. B., Lof A., Osterman-Golkar S., Walles S. A. S. Covalent binding of styrene and styrene-7,8-oxide to plasma proteins, hemoglobin and DNA in the mouse. Chem. Biol. Interact 1985; 55: 63
   PubMed Web of Science ®Google Scholar
• Schalm O. W., Jain N. C., Jain A. H., Carroll E. J. Veterinary Hematology, 3rd ed. W. B. Saunders, Philadelphia 1975
   Google Scholar
• Hemminki K., Savolainen H. Alkylation of rat serum proteins by dimethylnitrosamine and acetyl aminofluorene. Toxicol. Lett. 1980; 6: 433
   PubMed Web of Science ®Google Scholar
• Skipper P. L., Obiedzinski M. W., Tannenbaum S. R., Miller D. W., Mitchum R. K., Kadlubar F. F. Identification of the major serum albumin adduct formed by 4-aminobiphenylin vivo in rats. Cancer Res. 1985; 45: 5122
   PubMed Web of Science ®Google Scholar
• Tannenbaum S. R., Skipper P. L. Biological aspects to the evaluation of risk: dosimetry of carcinogens in man. Fundam. Appl. Toxicol. 1984; 4: S367
   Google Scholar
• Can L. S., Skipper P. L., Peng X., Groopman J. D., Chen J., Wogan G. N., Tannenbaum S. R. Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M. Carcinogenesis 1988; 9: 1323
   PubMed Web of Science ®Google Scholar
• Sun J. D., Dent J. G. Macrornolecular weight specificity in covalent binding of bromobenzene. Toxicol. Appl. Pharmacol. 1984; 76: 243
   PubMed Web of Science ®Google Scholar
• Sega G. A., Valdivia Alcota R. P., Tancogeno C. P., Brimer P. A. Acrylamide binding to the DNA and protamine of spermagenic stages in the mouse and its relationship to genetic damage. Mutat. Res., in press
   Google Scholar
• Lewalter J., Korallus U. Blood protein conjugates and acetylation of aromatic amines. New findings on biological monitoring. Int. Arch. Environ. Health 1985; 56: 179
   PubMed Web of Science ®Google Scholar
• Green L. C., Skipper P. L., Turesky R. J., Bryant M. S., Tannenbaum S. R. In vivo dosimetry of 4-aminobiphenyl in rats via a cysteine adduct in haemoglobin. Cancer Res. 1984; 44: 4254
   PubMed Web of Science ®Google Scholar
• Skipper P. L., Bryant M. S., Tannenbaum S. R., Groopman J. D. Analytical methods for assessing exposure to 4-aminophenyl based on protein adduct formation. J. Occup. Med. 1986; 28: 643
   PubMedGoogle Scholar
• Santella R. M., Lin D. C., Cleveland W. L., Weinstein I. B. Monoclonal antibodies to DNA modified by a benzo(a)pyrene diol epoxide. Carcinogenesis 1984; 5: 373
   PubMed Web of Science ®Google Scholar
• Shugart L. Quantitating exposure to chemical carcinogens: invivo aikylation of hemoglobin by benzo(a)pyrene. Toxicology 1985; 34: 211
   PubMed Web of Science ®Google Scholar
• Bryant M. S., Skipper P. L., Tannenbaum S. R., Maclure M. Hemoglobin adducts of 4-aminobiphenyl in smokers and non-smokers. Cancer Res. 1987; 47: 602
   PubMed Web of Science ®Google Scholar
• Tornqvist M., Mowrer J., Jensen S., Ebrenberg L. Monitoring of environmental cancer initiators through hemoglobin adducts by modified Edman degradation method. Anal. Biochem. 1986; 154: 255
   PubMed Web of Science ®Google Scholar
• Bailey E., Farmer P. B., Shuker D. E. G. Estimation of exposure to alkylating carcinogens by the GC-MS determination of adducts to hemoglobin and nucleic acid bases in urine. Arch. Toxicol. 1987; 60: 187
   PubMed Web of Science ®Google Scholar
• Mowrer J., Tornqvist M., Jensen S., Ehrenberg L. Modified Edman degradation applied to hemoglobin for monitoring occupational exposure to alkylating agents. Toxicol. Environ. Chem. 1986; 11: 215
   Web of Science ®Google Scholar
• Evelo C. T. A., Niessen H. J. J.M., Roelofs H. M. J., Henderson Th. P. Cysteine adducts of human haemoglobin measured by isoelectric focusing in polyacrylamide gels with a nonlinear pH gradient. J. Chromatogr. 1987; 420: 35
   PubMed Web of Science ®Google Scholar
• Weinstein I. B. The monitoring of DNA adducts as an approach to carcinogen detection. Annu. Rev. Public Health 1983; 4: 109
   Web of Science ®Google Scholar
• Rahn R. O., Change S. S., Holland J. M., Shugart L. R. A fluorometric-HPLC assay for quantitating the binding of benzo(a)pyrene metabolites to DNA. Biochem. Biophys. Res. Commun. 1982; 109: 262
   PubMed Web of Science ®Google Scholar
• Vahakangas K., Trivers G., Rowe M., Harris C. C. Benzo(a)pyrene diol epoxide-DNA adducts detected by synchronous fluorescence spectrophotometry. Environ. Health Perspect 1985; 62: 101
   PubMed Web of Science ®Google Scholar
• Hsu I.-C., Poirier M. C., Yuspa S. H., Grunberger D., Weinstein I. B., Yolken R. H., Harris C. C. Measurement of benzo(a)pyrene-DNA adducts by enzyme immunoassays and radioimmunoassay. Cancer Res. 1981; 41: 1091
   PubMed Web of Science ®Google Scholar